Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|May 10, 2012

Poll of the Week: Reading PET Studies for Alzheimer's?

New diagnostic agents for use with PET imaging are improving identification of beta-amyloid, the brain plaque associated with Alzheimer’s disease. But there are some concerns about training to accurately read these studies.

New radioactive diagnostic agents for use with PET imaging are improving identification of beta-amyloid, the brain plaque associated with Alzheimer’s disease. But there are some concerns that radiologists and technologists don’t have enough training to accurately read these PET studies. What do you think?

 

 


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.